The important regulatory functions of LINC02568 for ERα‐target gene activation and pH homeostasis, and therefore tumor growth and drug resistance in ER+ breast cancer cells prompt us to explore the potential of LINC02568 as a therapeutic target. This evidence concerns the gene ESR1 and breast cancer.